What Ambulance partner does

Ambulanzpartner Soziotechnologie APST GmbH is a Berlin-based digital health company operating a care coordination platform for patients with ALS (Amyotrophic Lateral Sclerosis), SMA (Spinal Muscular Atrophy), and other motor neuron diseases. The platform links three stakeholder groups: patients (who register free of charge), medical partners such as doctors, therapists, and social service providers (who also access the platform free of charge), and supply partners including pharmacies, medical supply stores, and medical device manufacturers (who pay license fees). The company's core product is the Ambulanzpartner Versorgungsportal (APVP), a structured database with an associated web portal that captures, stores, and processes patient and care-related data, complemented by mobile applications (ALS App and SMA App) for patient-reported outcomes and disease monitoring.

The platform integrates clinical assessment scales (ALSFRS-r, ALSFRS-ex, EQ-5D-5L, MYMOP, NPS, TSQM) and is hosted on Charité – Universitätsmedizin Berlin infrastructure to meet healthcare data security standards. Since 2011, the company has enrolled over 10,422 ALS patients and built a care network of 20 ALS centers in Germany. The platform is available in 18 countries across Europe, North America, and Africa, with a UK office in Brentford supporting international operations.

Revenue is generated primarily through license fees from supply partners and the monetization of pseudonymized patient data for healthcare research in cooperation with academic institutions and healthcare companies. APST Research GmbH operates as a wholly-owned subsidiary to formalize research activities. The company is privately held, with no disclosed funding rounds, and is led by managing directors Prof. Dr. Thomas Meyer and Prof. Dr. Christoph Münch.

Name

Ambulance partner

Legal name

Ambulanzpartner Soziotechnologie APST GmbH

Website

https://ambulanzpartner.de

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Ambulanzpartner is a Berlin-based digital health platform providing care coordination for patients with ALS, SMA, and other motor neuron diseases, connecting them with medical partners and supply partners across 18 countries.

Ownership category

akta.pro rank

Product category

Digital Health Platform

NAICS

Health Care and Social Assistance (62), Home Health Care Services (621610)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)

akta.pro secondary industry

Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

• Digital health platform
• Care coordination
• Patient registry
• Rare disease management
• Medical research platform

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Supply Partner License Fees: Supply partners (providers, manufacturers, or suppliers of medical devices, aids, remedies, medication, or care services) pay a license fee for using the APVP internet platform and APST services. Fees cover maintenance, refinancing of IT and service architecture, and further development of the platform.
2. Care Research Data Partnerships: APST generates revenue through analysis of pseudonymized/anonymized patient data for healthcare research in cooperation with academic institutions and healthcare companies, supporting development of medical technology, medications, and treatment methods.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Ambulanzpartner operates a digital care coordination and medical research platform (APVP) for patients with ALS, SMA, and other motor neuron diseases. The platform links patients, medical partners (doctors, therapists, social services), and supply partners (pharmacies, medical supply stores) to coordinate assistive devices, therapies, medication, and nutritional support. Patients participate via web portal and mobile apps (ALS App and SMA App) that collect longitudinal symptom and treatment data used both for individual care and for academic and industry research partnerships.

Product overview

Ambulanzpartner Soziotechnologie APST GmbH offers a unified digital care platform for patients with rare neurological diseases (primarily ALS, SMA, and other motor neuron diseases). The core product is the Ambulanzpartner Versorgungsportal (APVP) — a structured database with an associated web portal that electronically captures, stores, and processes patient and care-related data. This platform is complemented by two mobile applications: the ALS App and the SMA App, which enable patients to participate in surveys and record disease progression. APST delivers care management as a set of service modules (assistive device provision, therapeutic services, medication supply, nutritional support, and respiratory care) that can be used together or individually. The platform also supports care research, using pseudonymised and anonymised data for scientific and health economic analyses in cooperation with academic and healthcare sector partners. All services are hosted on Charité – Universitätsmedizin Berlin infrastructure.

Differentiator

Problem solved

Functional benefit

Brands

• ALS-App: Mobile application enabling ALS patients to participate in surveys and evaluate disease symptoms, symptom progression, and treatment experience.
• SMA-App
• Ambulanzpartner Versorgungsportal

Products and services

• Ambulanzpartner Versorgungsportal (APVP)

Quantifiable outcome

• 10,422 ALS patients enrolled since 2011 demonstrating platform scale and adoption
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core, major and minor.

• Charité – Universitätsmedizin BerlincoreStrategic or Co-development PartnerAPST works with Charité – Universitätsmedizin Berlin to provide the APVP internet portal and related services. Charité provides hosting services for the platform, including data protection, data security, and healthcare research cooperation. Charité servers meet the particular requirements for data security and data privacy of health data. APST is the contracting party and responsible entity pursuant to GDPR.
• Medical Partners NetworkcoreStrategic or Co-development PartnerMedical partners including doctors, dieticians, nursing staff, care advisors, social counselors, and teams in clinics and practices participate in the APST network. They support patients in determining or fulfilling care needs and benefit from electronic care records and specialized case management. Medical partners access the platform free of charge.
• Supply Partners NetworkcoreChannel Partner/ Reseller/ DistributorSupply partners including pharmacies, medical supply stores (Sanitätshäuser), and providers of assistive devices, remedies, medication, and care services pay license fees to access the APVP platform. They benefit from coordinated care processes and patient ratings displayed on the platform.
• Academic Research InstitutionsmajorStrategic or Co-development PartnerAPST cooperates with academic institutions for healthcare research purposes, analyzing pseudonymized patient data to promote advancement of medical treatments. Research includes systematic analysis of necessary assistive technology devices over the course of ALS, SMA, and other neurological diseases.
• Healthcare Industry CompaniesminorStrategic or Co-development PartnerAPST cooperates with companies from the healthcare sector to promote development and advancement of medical technology, medicines, other medical products, or treatment methods through analysis of patient experience data.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• IXICO: Provides neuroimaging-based clinical trial services and digital biomarkers for neurological indications, including ALS. Comparable at the intersection of rare neurological diseases and clinical-research data analytics, an adjacent capability to APST's care-research modules.
• Medable: Decentralized clinical-trial technology platform enabling remote consent, eCOA, and patient-data capture across sites. Comparable to APST's mobile apps (ALS App / SMA App) on the trial-research tooling axis; both compete for trial recruitment budgets in rare indications.
• Within3: Engagement platform for clinical and medical research communities, focused on connecting life-science teams with physicians, patients, and advisors. Comparable as a digital research-engagement infrastructure layer that could converge with APST's research-revenue line.

Direct peers

• HealthUnlocked: UK-based digital health platform offering condition-specific peer-support communities and integrated health-tracking tools, with a model of serving both patient-users and healthcare/life-sciences partners — directly analogous to APST's patient + medical + supply-partner triangle.
• MyHealthTeams: Operates condition-specific social health networks covering chronic and rare diseases, combining patient community, daily tracking, and partnerships with pharma and providers. Highly comparable business model to APST's targeted rare-disease community + research platform.
• Mendel: Clinical-trial and observational-research platform that structures structured EHR data for rare-disease indications to accelerate trial recruitment and evidence generation. Adjacent but increasingly direct competitor to APST on the research-data revenue stream.
• PatientsLikeMe: Patient-powered research and digital data network enabling people with chronic conditions to track symptoms, share outcomes, and contribute to real-world evidence. Directly comparable to APST's combination of patient engagement, longitudinal symptom capture, and research-data monetization across serious/rare conditions.
• Raremark: Digital rare-disease patient-engagement platform that provides structured education, treatment tracking, and aggregated, anonymized data for pharma research and trial recruitment. Closest pure-play peer to APST's rare-disease focus and research-revenue model.

Regional players

• Soleo Health: US-based specialty/home-infusion and care-coordination provider serving rare and chronic disease patients in their homes. Comparable as a care-coordination counterpart for high-acuity rare-disease therapies, with APST focused on Germany/Europe and Soleo in the US.

Others

• Cure SMA: US-based patient-advocacy organization focused on Spinal Muscular Atrophy, funding research and supporting patients/families. Ecosystem complement rather than competitor — overlap with APST's SMA user base signals a potential partnership channel for patient referrals, engagement, and joint research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/ambulanzpartner

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ambulance partner